Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B&G Foods, Inc. stock logo
BGS
B&G Foods
$4.22
-1.2%
$4.30
$3.67
$9.44
$336.82M0.482.82 million shs1.43 million shs
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.45
+1.3%
$47.23
$42.96
$63.33
$98.60B0.3612.72 million shs11.21 million shs
CVS Health Corporation stock logo
CVS
CVS Health
$68.56
+2.7%
$64.96
$43.56
$72.51
$87.01B0.589.02 million shs8.25 million shs
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$44.24
+1.7%
$42.68
$37.58
$47.35
$186.53B0.3618.44 million shs21.23 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B&G Foods, Inc. stock logo
BGS
B&G Foods
0.00%+3.69%+2.30%-4.63%-49.16%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.00%+5.42%+0.80%+3.59%+0.08%
CVS Health Corporation stock logo
CVS
CVS Health
0.00%+4.69%+8.24%+9.68%+22.45%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
0.00%+2.60%+8.00%+0.61%+8.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
B&G Foods, Inc. stock logo
BGS
B&G Foods
3.7064 of 5 stars
2.92.01.71.92.02.50.6
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
4.7726 of 5 stars
2.15.04.24.03.52.51.3
CVS Health Corporation stock logo
CVS
CVS Health
4.9958 of 5 stars
3.53.03.33.94.13.33.8
Verizon Communications Inc. stock logo
VZ
Verizon Communications
4.7051 of 5 stars
2.33.05.03.53.61.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
B&G Foods, Inc. stock logo
BGS
B&G Foods
1.80
Reduce$6.1044.55% Upside
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.24
Hold$56.3816.36% Upside
CVS Health Corporation stock logo
CVS
CVS Health
3.00
Buy$76.0010.85% Upside
Verizon Communications Inc. stock logo
VZ
Verizon Communications
2.60
Moderate Buy$47.357.04% Upside

Current Analyst Ratings Breakdown

Latest CVS, BMY, VZ, and BGS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2025
CVS Health Corporation stock logo
CVS
CVS Health
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/14/2025
CVS Health Corporation stock logo
CVS
CVS Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$71.00 ➝ $82.00
8/5/2025
B&G Foods, Inc. stock logo
BGS
B&G Foods
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$6.00 ➝ $5.00
8/5/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Daiwa America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/5/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Daiwa Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$42.00
8/4/2025
CVS Health Corporation stock logo
CVS
CVS Health
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
8/1/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$51.00 ➝ $47.00
8/1/2025
CVS Health Corporation stock logo
CVS
CVS Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $82.00
8/1/2025
CVS Health Corporation stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$79.00 ➝ $80.00
7/31/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
7/22/2025
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$71.00 ➝ $67.00
(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
B&G Foods, Inc. stock logo
BGS
B&G Foods
$1.93B0.17$6.81 per share0.62$6.27 per share0.67
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$48.30B2.04$5.89 per share8.23$8.59 per share5.64
CVS Health Corporation stock logo
CVS
CVS Health
$372.81B0.23$9.08 per share7.55$61.14 per share1.12
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$134.79B1.38$8.85 per share5.00$24.75 per share1.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
B&G Foods, Inc. stock logo
BGS
B&G Foods
-$251.25M-$2.83N/A6.30N/A-12.02%7.16%1.34%11/4/2025 (Estimated)
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
-$8.95B$2.4819.547.962.4810.58%80.04%14.69%10/30/2025 (Estimated)
CVS Health Corporation stock logo
CVS
CVS Health
$4.61B$3.5819.1510.130.761.17%10.51%3.15%11/5/2025 (Estimated)
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$17.51B$4.2910.319.103.4113.28%19.61%5.19%10/28/2025 (Estimated)

Latest CVS, BMY, VZ, and BGS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
B&G Foods, Inc. stock logo
BGS
B&G Foods
$0.07$0.04-$0.03-$0.12$427.80 million$424.43 million
7/31/2025Q2 2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$1.07$1.46+$0.39$0.64$11.32 billion$12.27 billion
7/31/2025Q2 2025
CVS Health Corporation stock logo
CVS
CVS Health
$1.46$1.81+$0.35$0.80$94.87 billion$98.92 billion
7/21/2025Q2 2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$1.19$1.22+$0.03$1.19$33.47 billion$34.50 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
B&G Foods, Inc. stock logo
BGS
B&G Foods
$0.7618.01%N/AN/A N/A
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$2.485.12%N/A100.00%17 Years
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.88%N/A74.30%4 Years
Verizon Communications Inc. stock logo
VZ
Verizon Communications
$2.716.13%N/A63.17%20 Years

Latest CVS, BMY, VZ, and BGS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2025
B&G Foods, Inc. stock logo
BGS
B&G Foods
quarterly$0.1917.82%9/30/20259/30/202510/27/2025
6/17/2025
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
quarterly$0.625.25%7/3/20257/3/20258/1/2025
7/7/2025
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.99%7/22/20257/22/20258/1/2025
6/6/2025
Verizon Communications Inc. stock logo
VZ
Verizon Communications
quarterly$0.67756.22%7/10/20257/10/20258/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
B&G Foods, Inc. stock logo
BGS
B&G Foods
3.96
2.93
0.89
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2.54
1.21
1.11
CVS Health Corporation stock logo
CVS
CVS Health
0.74
0.80
0.62
Verizon Communications Inc. stock logo
VZ
Verizon Communications
1.19
0.64
0.60

Institutional Ownership

CompanyInstitutional Ownership
B&G Foods, Inc. stock logo
BGS
B&G Foods
66.15%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
76.41%
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
62.06%

Insider Ownership

CompanyInsider Ownership
B&G Foods, Inc. stock logo
BGS
B&G Foods
3.20%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
0.09%
CVS Health Corporation stock logo
CVS
CVS Health
1.22%
Verizon Communications Inc. stock logo
VZ
Verizon Communications
0.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
B&G Foods, Inc. stock logo
BGS
B&G Foods
2,78480.00 million77.44 millionOptionable
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
34,1002.04 billion2.03 billionOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.27 billion1.25 billionOptionable
Verizon Communications Inc. stock logo
VZ
Verizon Communications
99,6004.22 billion4.21 billionOptionable

Recent News About These Companies

3 Dividend Stocks to Hold for the Next 5 Years
person counting one hundred dollar bills
3 Long-Term Dividend Buys You Can Get for Under $50 (VZ)
...

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
B&G Foods stock logo

B&G Foods NYSE:BGS

$4.22 -0.05 (-1.17%)
Closing price 08/15/2025 03:58 PM Eastern
Extended Trading
$4.25 +0.03 (+0.71%)
As of 08/15/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

B&G Foods, Inc. is a holding company, which engages in the manufacture, sale, and distribution of shelf-stable frozen food, and household products in the U.S., Canada, and Puerto Rico. It operates through the following segments: Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions. The Specialty segment includes, among others, the Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma’s, New York Style, Don Pepino, Sclafani, B&M, Baker’s Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit brands. The Meals segment focuses on the Ortega, Maple Grove Farms, Cream of Wheat, Las Palmas, Victoria, Mama Mary’s, Spring Tree, McCann’s, Carey’s and Vermont Maid brands. The Frozen & Vegetables segment consists of Green Giant and Le Sueur brands. The Spices & Flavor Solutions segment offers Dash, Spice Islands, Weber, Ac’cent, Tone’s, Trappey’s, Durkee and Wright’s brands. Its products include frozen and canned vegetables, hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. Its brands include Back to Nature, Bear Creek, Cream of Wheat, Green Giant, Mrs. Dash, and Ortega. The company was founded in 1889 and is headquartered in Parsippany, NJ.

Bristol Myers Squibb stock logo

Bristol Myers Squibb NYSE:BMY

$48.45 +0.64 (+1.34%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$48.50 +0.05 (+0.10%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

CVS Health stock logo

CVS Health NYSE:CVS

$68.56 +1.83 (+2.74%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$68.45 -0.11 (-0.16%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Verizon Communications stock logo

Verizon Communications NYSE:VZ

$44.24 +0.74 (+1.70%)
Closing price 08/15/2025 03:59 PM Eastern
Extended Trading
$44.18 -0.06 (-0.14%)
As of 08/15/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.